Paul ashton

Company: Inflammasome Therapeutics

Job title: President & Chief Executive Officer

Seminars:

Inhibiting Caspase-1 & Inflammasome Activation: Preclinical Data & Clinical Observations 11:00 am

Inhibiting caspase-1 and inflammasome activation in vivo Reversing cognitive decline in 5XFAD mice Clinical use associated with reduced incidence of ADRead more

day: Discovery Track Day 2 AM